Results 251 to 260 of about 1,267,436 (286)
Some of the next articles are maybe not open access.
Basic & Clinical Pharmacology & Toxicology, 2014
AbstractInternational Non‐proprietary Name (INN) prescribing is the use of the name of the active ingredient(s) instead of the brand name for prescribing. In Belgium, INN prescribing began in 2005 and a major policy change occurred in 2012. The aim was to explore the opinions of Dutch‐speaking general practitioners (GPs) and pharmacists.
Van Bever, Elien +5 more
openaire +3 more sources
AbstractInternational Non‐proprietary Name (INN) prescribing is the use of the name of the active ingredient(s) instead of the brand name for prescribing. In Belgium, INN prescribing began in 2005 and a major policy change occurred in 2012. The aim was to explore the opinions of Dutch‐speaking general practitioners (GPs) and pharmacists.
Van Bever, Elien +5 more
openaire +3 more sources
2017
Supplementary Material - Use_of_Proprietary_Names_by_Prescribers_for_Generic_Products_Supplementary_Table - Use of Proprietary Names by Prescribers for Generic Products by Vicky Borders-Hemphill, Irene Z. Chan, Katelyn Brown, Briana Rider, Kellie Taylor, and Grace Chai in Therapeutic Innovation & Regulatory ...
Borders-Hemphill, Vicky +5 more
openaire +1 more source
Supplementary Material - Use_of_Proprietary_Names_by_Prescribers_for_Generic_Products_Supplementary_Table - Use of Proprietary Names by Prescribers for Generic Products by Vicky Borders-Hemphill, Irene Z. Chan, Katelyn Brown, Briana Rider, Kellie Taylor, and Grace Chai in Therapeutic Innovation & Regulatory ...
Borders-Hemphill, Vicky +5 more
openaire +1 more source
Prescribing generic drugs using a generic name: Are we teaching it right?
Indian Journal of Medical Ethics, 2016The Indian Medical Council (Professional conduct, Etiquette and Ethics) Regulations, 2002, state that "Every physician should, as far as possible, prescribe drugs with generic names and he/she shall ensure that there is a rational prescription and use of drugs.".
openaire +2 more sources
Increase in payments for neurologist-prescribed brand name drugs
PharmacoEconomics & Outcomes News, 2021openaire +1 more source
A survey of Australian prescribers’ views on the naming and substitution of biologicals
Generics and Biosimilars Initiative Journal, 2017Stephen P Murby, Michael S Reilly
openaire +1 more source
Industry interaction increases brand name prescribing
PharmacoEconomics & Outcomes News, 2020openaire +1 more source

